No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
771 |
4. Check minimum number of eventsNone |
771 |
5. Include endpointsNone |
771 |
6. Filter based on genotype QC (FinnGen only) |
771 |
Control definitions (FinnGen only)
- Control exclude
- H7_EYEOTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Anomalies of pupillary function
based on the number of shared cases.
Similar with more cases:
- Other disorders of eye and adnexa
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5859 | 3670 | 2172 |
| Only index persons | 5135 | 3304 | 1831 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.11 | 0.06 |
| Only index persons | 0.10 | 0.12 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 38.54 | 40.94 | 34.48 |
| Only index persons | 41.34 | 42.94 | 38.47 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 771 | 548 | 223 |
| Unadjusted period prevalence (%) | 0.16 | 0.19 | 0.10 |
| Median age at first event (years) | 45.97 | 45.95 | 46.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 675
- Matched controls
- 6749
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H57.0
ICD-10 Finland
Anomalies of pupillary function
4503599627370496.0
323.0
650
*
G90.2
ICD-10 Finland
Horner syndrome
41.9
26.0
32
8
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
24.6
156
597
AA1AD
NOMESCO Finland
CT of head and brain
2.7
22.0
175
769
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
15.9
81
261
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
15.1
89
317
H57.1
ICD-10 Finland
Ocular pain
6.6
14.2
36
57
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.4
13.4
67
213
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
13.1
71
240
R51.80
ICD-10 Finland
Headache
2.3
12.4
130
641
R42
ICD-10 Finland
Dizziness and giddiness
2.2
12.2
137
697
XCK00
NOMESCO Finland
Perimetry
3.4
11.8
57
177
37834
ICD-8 Finland
Other diseases of eye, Deformatio pupillae. Anisocoria. Miosis. Mydriasis
+∞
11.5
11
*
Q13.2
ICD-10 Finland
Other congenital malformations of iris
35.7
11.3
14
*
R03AC02
ATC
salbutamol; inhalant
1.7
11.0
371
2787
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.5
10.9
38
89
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.0
10.6
33
68
H53.1
ICD-10 Finland
Subjective visual disturbances
3.2
10.0
52
171
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
10.0
59
212
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
10.0
149
848
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
9.7
69
279
H53.2
ICD-10 Finland
Diplopia
5.6
9.6
27
50
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.5
252
1738
A02BA02
ATC
ranitidine; systemic
2.1
9.2
115
609
H53.9
ICD-10 Finland
Visual disturbance, unspecified
4.5
8.8
30
69
L01
ICPC
Neck symptom/complaint
2.1
8.7
101
519
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
8.6
172
1078
N06AX11
ATC
mirtazapine; oral
1.7
8.6
206
1369
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
27.9
8.5
11
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
8.5
238
1654
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.3
149
901
M79.6
ICD-10 Finland
Pain in limb
1.7
8.3
230
1594
M01AB05
ATC
diclofenac; systemic, rectal
1.6
7.7
410
3335
H20.1
ICD-10 Finland
Chronic iridocyclitis
6.6
7.5
18
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.2
241
1740
Z71.8
ICD-10 Finland
Other specified counselling
1.7
7.1
165
1076
M25.5
ICD-10 Finland
Pain in joint
1.7
7.1
191
1302
G44.2
ICD-10 Finland
Tension-type headache
2.0
7.1
97
531
F29
ICPC
Eye symptom/complaint other
2.3
7.1
63
286
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
7.0
71
344
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
6.9
153
982
N05AH04
ATC
quetiapine; oral
1.8
6.9
115
677
TAB00
NOMESCO Finland
Lumbar puncture
3.0
6.8
37
128
S06.0
ICD-10 Finland
Concussion
2.1
6.8
76
385
R52.9
ICD-10 Finland
Pain, unspecified
2.4
6.8
57
253
H50.2
ICD-10 Finland
Vertical strabismus
16.9
6.8
10
6
R06AX27
ATC
desloratadine; oral
1.6
6.7
197
1371
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
6.6
318
2488
K04.0
ICD-10 Finland
Pulpitis
2.1
6.6
74
375
M54.5
ICD-10 Finland
Low back pain
1.6
6.6
212
1508
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.5
277
2103
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
6.5
91
505
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
6.3
76
395
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.0
6.3
80
428
S01GX02
ATC
levocabastine; ophthalmic
2.5
6.0
46
195
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
290
1663
2.19
23.01
2.2
2.1
u/l
144.3
219.2
1.10
273
1567
(3013826) Glucose [Moles/volume] in Serum or Plasma
456
3432
1.80
13.99
5.0
4.7
mmol/l
6.3
6.6
1.79
420
3153
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
381
2771
1.74
12.68
6.4
6.6
mmol/l
1.2
1.2
0.56
327
2356
(3013707) Erythrocyte sedimentation rate by Westergren method
561
4615
1.79
11.49
4.3
3.9
mm/h
10.6
10.8
0.17
527
4273
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
346
2526
1.67
10.79
5.7
5.9
mmol/l
1.2
1.2
1.50
316
2306
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
562
4671
1.75
10.58
7.2
6.9
u/l
76.6
77.6
0.23
538
4384
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
168
1033
1.80
9.58
4.2
3.5
ng/l
265.1
318.5
0.13
112
704
(3019550) Sodium [Moles/volume] in Serum or Plasma
706
6384
2.26
9.30
15.8
13.1
mmol/l
139.7
139.7
0.00
698
6199
(3024561) Albumin [Mass/volume] in Serum or Plasma
321
2369
1.61
9.15
4.2
4.5
g/l
36.3
36.2
0.18
308
2222
(3023103) Potassium [Moles/volume] in Serum or Plasma
707
6405
2.25
9.12
15.9
13.2
mmol/l
3.9
3.9
0.36
695
6206
(3001604) Monocytes [#/volume] in Blood
406
3171
1.59
9.09
6.4
5.8
e9/l
0.5
0.6
0.23
360
2776
(3013115) Eosinophils [#/volume] in Blood
418
3297
1.58
8.90
6.5
6.1
e9/l
0.2
0.2
0.08
371
2931
(3018418) pH of Serum or Plasma
240
1675
1.63
8.46
3.2
3.7
ph
7.4
7.4
0.72
40
309
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
393
3080
1.56
8.43
5.5
5.9
umol/l
12.8
10.7
0.54
362
2909
(3006315) Basophils [#/volume] in Blood
404
3187
1.56
8.41
6.5
5.8
e9/l
0.0
0.0
0.06
359
2790
(3032080) INR in Blood by Coagulation assay
290
2122
1.59
8.39
6.7
7.3
inr
1.1
1.2
0.24
84
655
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
38
135
2.91
8.22
1.0
1.5
e6/l
515.8
128.8
0.59
29
109
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
135
2.91
8.22
1.0
1.4
e6/l
5.2
11.8
0.43
27
105
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
703
6401
2.11
8.19
15.0
11.9
mg/l
20.0
21.4
0.61
567
4972
(3019198) Lymphocytes [#/volume] in Blood
411
3287
1.54
7.82
6.6
5.8
e9/l
2.0
2.0
0.30
366
2931
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
254
1833
1.58
7.65
2.5
2.4
u/l
57.2
55.6
0.34
238
1705
(3044290) Cell count panel - Cerebral spinal fluid
34
119
2.94
7.57
1.0
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
447
3667
1.52
7.37
8.9
8.7
e9/l
3.9
4.0
0.62
390
3233
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
662
5955
1.79
7.34
6.0
4.8
mu/l
1.8
2.0
0.47
619
5523
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
275
2042
1.54
7.21
3.2
3.2
ng/l
63.8
54.4
0.09
151
1231
(42870588) Differential panel, method unspecified - Blood
276
2054
1.54
7.15
6.5
5.9
—
—
—
0
0
(3044889) 12 lead EKG panel
493
4144
1.53
7.14
3.6
3.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
204
1422
1.59
7.04
1.8
1.7
mg/l
1.7
1.0
0.51
143
1079
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
80
427
1.97
6.99
3.0
3.4
pmol/l
4.5
4.6
0.57
70
377
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
581
5076
1.59
6.96
5.1
4.1
pmol/l
14.6
14.6
0.24
542
4670
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
69
353
2.05
6.78
2.7
2.8
ng/l
98.8
159.1
1.55
63
318
(3006504) Eosinophils/100 leukocytes in Blood
373
2984
1.48
6.70
6.6
5.9
%
2.8
2.8
0.15
357
2791
(3022096) Basophils/100 leukocytes in Blood
361
2878
1.48
6.55
6.6
6.0
%
0.7
0.7
0.21
346
2696
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
277
2098
1.50
6.46
3.4
3.1
u/l
31.5
30.5
0.23
259
2009
(3019069) Monocytes/100 leukocytes in Blood
372
2995
1.47
6.35
6.8
6.2
%
8.2
8.3
0.41
358
2822
(3037467) Urinalysis macro (dipstick) panel - Urine
504
4309
1.49
6.31
4.7
4.0
—
—
—
0
0
(3015736) pH of Urine
312
2432
1.48
6.26
3.1
3.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
382
3099
1.46
6.23
6.6
6.0
%
29.6
29.1
0.43
362
2907
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
292
2253
1.48
6.14
1.9
1.9
pmol/l
99.4
96.2
0.57
150
1170
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
213
1546
1.52
6.02
1.7
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
98
595
1.74
5.71
1.7
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
225
1668
1.49
5.70
1.3
1.3
u/ml
0.7
1.9
2.06
54
462
(3018010) Neutrophils/100 leukocytes in Blood
375
3068
1.43
5.65
6.5
5.7
%
56.0
56.4
0.29
358
2894
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
47
3.68
5.50
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
202
1483
1.49
5.32
2.1
2.1
mg/l
2.4
2.9
4.13
176
1279
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
723
6806
2.00
5.28
11.2
9.3
u/l
26.1
26.0
0.06
699
6579
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
162
1142
1.53
5.16
1.3
1.3
iu/ml
20.2
29.5
1.08
54
378
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
129
866
1.59
5.10
1.7
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
60
3.22
5.07
1.1
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
136
2.41
4.96
1.3
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
203
1511
1.47
4.95
4.3
3.7
%
93.6
94.2
0.14
196
1472
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
96
603
1.68
4.94
1.7
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
101
643
1.66
4.94
7.8
7.1
mmol/l
104.1
104.1
0.05
95
630
(3019150) Specific gravity of Urine by Refractometry
189
1388
1.48
4.93
3.4
3.6
kg/l
1.0
1.0
0.52
28
185
(3027801) Oxygen [Partial pressure] in Arterial blood
90
556
1.70
4.93
7.2
9.1
kpa
12.3
12.5
0.22
84
538
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
90
556
1.70
4.93
7.3
9.1
kpa
5.1
5.2
0.09
84
536
(44813793)
18
56
3.27
4.92
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
176
1276
1.49
4.89
1.4
1.5
nmol/l
21.4
21.3
0.02
156
1100
(3012095) Magnesium [Moles/volume] in Serum or Plasma
131
892
1.56
4.86
2.6
3.7
mmol/l
0.8
0.8
0.30
118
840
(3003396) Base excess in Arterial blood by calculation
89
551
1.70
4.84
7.3
9.2
mmol/l
1.2
1.2
0.06
71
445
(3048689) Calprotectin [Mass/mass] in Stool
127
867
1.56
4.66
2.3
2.3
ug/g
100.7
122.0
0.41
100
675
(3002385) Erythrocyte distribution width [Ratio]
612
5565
1.48
4.65
17.7
14.5
%
13.4
13.5
0.97
602
5462
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
25
4.45
4.57
1.0
1.0
ng/l
854.0
607.4
—
6
15
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
25
4.45
4.57
1.0
1.0
ng/l
225.3
315.7
—
6
15
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
25
4.45
4.57
1.0
1.0
ng/l
23.8
46.2
—
6
14
(3026008) Bacteria identified in Urine by Culture
234
1812
1.42
4.56
3.1
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
372
3119
1.37
4.49
3.4
3.4
estimate
0.0
0.0
0.00
60
604
(3016018) Differential panel - Cerebral spinal fluid
17
55
3.14
4.38
1.0
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
754
7264
2.72
4.36
21.9
17.5
e12/l
4.5
4.5
0.23
742
7076
(40761511) CBC panel - Blood by Automated count
718
6797
1.82
4.35
13.3
10.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
754
7267
2.70
4.30
21.9
17.6
e9/l
6.8
6.7
0.58
741
7071
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
249
1.95
4.26
10.9
13.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
258
2053
1.39
4.24
3.1
3.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
16
51
3.18
4.22
1.0
1.1
mg/l
196.2
232.4
0.88
16
42
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
650
6015
1.51
4.22
4.1
4.0
mmol/l
5.8
5.8
0.14
602
5526
(3007461) Platelets [#/volume] in Blood
753
7259
2.60
4.18
21.9
17.5
e9/l
256.8
257.2
0.06
743
7087
(3021601) Nitrite [Presence] in Urine by Test strip
371
3133
1.35
4.17
4.9
4.6
estimate
0.0
0.0
0.50
63
612
(3015377) Calcium [Moles/volume] in Serum or Plasma
246
1954
1.38
4.05
2.8
3.2
mmol/l
2.3
2.4
1.25
216
1728
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
89
578
1.61
4.03
3.1
2.3
u/l
31.4
118.0
0.52
77
482
(3001122) Ferritin [Mass/volume] in Serum or Plasma
358
3018
1.35
4.02
2.7
2.8
ug/l
89.0
92.5
0.16
337
2819
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
179
1349
1.43
4.00
2.5
3.0
ng/l
947.8
880.2
0.11
140
1112
(36660697) Celiac disease serology panel - Serum
88
572
1.61
3.98
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
564
1.61
3.97
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
151
1107
1.45
3.91
1.3
1.3
u/ml
9.1
10.3
0.07
64
438
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
102
690
1.55
3.89
2.3
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
156
1155
1.44
3.83
1.7
1.6
pmol/l
434.7
27500434.7
1.31
134
1000
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
39
706
0.53
3.78
1.6
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
371
3169
1.33
3.72
3.5
3.4
estimate
0.0
0.0
0.80
63
597
(3019060) Gas panel - Arterial blood
52
299
1.79
3.69
4.5
6.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
112
783
1.50
3.67
1.7
1.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
16
56
2.90
3.64
1.1
1.1
iu/ml
14.9
6.4
—
8
11
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
18
68
2.69
3.58
1.0
1.1
—
—
—
0
0
(4027681)
14
47
3.02
3.42
1.1
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
42
232
1.86
3.40
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
129
943
1.44
3.38
2.8
2.5
e6/l
1.2
1.0
0.17
71
520
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
83
555
1.56
3.35
1.9
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
125
912
1.44
3.31
1.3
1.3
titre
585.5
532.3
0.08
22
192
(3052851) Hemolysis interference index of Serum or Plasma
33
171
1.97
3.24
2.7
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
132
2.08
3.10
3.1
3.0
u/ml
0.4
0.3
0.23
17
70
(3005719) IgG [Mass/volume] in Serum or Plasma
73
483
1.56
3.09
2.7
2.9
g/l
10.7
10.4
0.25
68
443
(3023368) Bacteria identified in Blood by Culture
179
1406
1.36
3.07
4.1
3.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
13
5.42
2.87
1.7
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
32
172
1.90
2.85
1.8
1.9
iu/l
4.7
5.0
0.05
15
61
(3007853) Bacteria identified in Skin by Aerobe culture
100
720
1.45
2.85
1.6
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
561
1.50
2.80
1.2
1.2
iu/ml
121.5
158.6
0.42
35
237
(3020891) Body temperature
35
195
1.83
2.80
3.6
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
128
969
1.38
2.75
2.7
2.6
mmol/l
2.4
2.4
0.38
114
847
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
46
280
1.68
2.74
1.7
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
118
882
1.40
2.73
1.9
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
523
4790
1.29
2.69
3.8
3.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
69
467
1.52
2.67
7.4
8.0
mmol/l
1.5
1.3
0.45
62
447
(3035320) C reactive protein [Mass/volume] in Body fluid
12
43
2.82
2.65
2.6
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
93
670
1.44
2.65
5.5
6.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
93
671
1.44
2.63
2.8
2.8
umol/l
10.5
6.5
0.30
79
574
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
364
1.58
2.59
1.9
2.3
nmol/l
12.3
12.6
0.08
48
333
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
600
5606
1.32
2.58
5.2
5.1
mmol/mol
38.8
38.9
0.06
566
5253
(3007566) Smooth muscle Ab [Titer] in Serum
31
171
1.85
2.58
1.1
1.2
titre
50.0
62.5
—
5
20
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
44
2.75
2.55
1.0
1.1
u/l
1.2
1.1
—
6
24
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
62
2.45
2.55
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
485
4415
1.27
2.55
3.1
3.0
u/l
46.3
43.1
0.22
451
4178
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
35
202
1.77
2.52
1.2
1.1
u/ml
3.9
7.1
—
5
34
(3009542) Hematocrit [Volume Fraction] of Blood
645
6097
1.35
2.51
16.9
12.8
%
40.1
40.1
0.10
476
4742
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
34
195
1.78
2.51
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
63
425
1.53
2.49
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
328
2863
1.25
2.45
9.1
8.5
e9/l
0.0
0.0
0.36
266
2359
(3025018) Bordetella pertussis Ab [Titer] in Serum
13
51
2.58
2.45
1.3
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
500
0.56
2.43
1.6
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
71
495
1.48
2.40
4.0
4.0
kpa
6.0
5.8
0.76
63
480
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
61
412
1.52
2.40
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
22
3.66
2.37
1.4
1.5
nmol/l
139.7
146.3
—
8
22
(3002032) Base excess in Venous blood by calculation
70
490
1.47
2.33
4.0
4.1
mmol/l
2.2
1.9
0.32
52
385
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
65
2.33
2.32
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
174
1415
1.30
2.31
3.8
3.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
71
500
1.46
2.29
2.2
2.5
g/l
0.2
0.2
0.62
66
476
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
284
2454
1.25
2.28
3.4
3.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
194
1.73
2.26
1.4
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
61
418
1.50
2.26
3.8
3.4
kpa
4.7
4.6
0.04
55
405
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
332
2922
1.24
2.25
3.7
3.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
207
2447
0.79
2.23
2.6
2.6
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
20
100
2.03
2.22
2.9
2.0
%
13.1
13.2
0.07
20
100
(46235355) HIV 1 and 2 tests - Meaningful Use set
195
1618
1.27
2.20
2.2
2.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
22
115
1.94
2.17
1.8
3.2
umol/l
31.9
34.7
0.22
17
97
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
41
260
1.61
2.14
8.3
11.2
mmol/l
24.9
24.3
0.73
36
248
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
115
892
1.34
2.13
3.0
2.6
e6/l
2.8
3.1
0.20
57
471
(3025159) Blasts/100 leukocytes in Blood
65
460
1.45
2.07
4.6
4.7
%
0.0
0.1
—
6
118
(40761535) Cells panel - Urine sediment
64
453
1.45
2.04
3.7
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
112
872
1.33
2.03
1.8
1.8
%
1.5
1.4
0.31
97
795
(36304419) Bacteria [Presence] in Urine
188
1574
1.26
1.96
3.1
2.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
46
307
1.53
1.95
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
11
4.57
1.94
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
193
1623
1.25
1.94
1.7
1.7
mmol/l
1.4
1.4
0.14
169
1393
(3030467) Casts [#/volume] in Urine by Automated count
190
1595
1.25
1.93
3.2
2.9
e6/l
0.2
0.4
0.87
135
1193
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
64
458
1.43
1.93
3.0
2.4
ml/min/173m2
79.8
71.8
0.83
28
189
(3000093) Morphology [Interpretation] in Blood Narrative
11
46
2.41
1.86
1.1
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
54
0.00
1.85
0.0
2.2
—
2.2
—
0
28
(3042936) Bacteria identified in Isolate by Culture
105
822
1.32
1.84
1.8
1.9
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
17
3.55
1.84
1.2
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
66
481
1.41
1.82
4.6
4.7
%
0.1
0.1
—
7
138
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
53
2.28
1.81
1.2
1.2
u/ml
1.6
0.1
—
6
20
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
23
3.06
1.80
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
69
508
1.39
1.79
4.5
4.6
%
1.0
0.9
—
8
152
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
109
1.86
1.78
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
55
390
1.44
1.76
1.6
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
18
3.35
1.75
1.2
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
18
3.35
1.75
5.2
6.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
115
920
1.29
1.73
1.9
1.7
nmol/l
1158.5
1198.4
0.21
89
703
(3022948) Iron [Moles/volume] in Serum or Plasma
108
857
1.30
1.73
1.8
2.3
umol/l
13.6
13.5
0.02
101
787
(3022145) Colonoscopy Study observation
88
681
1.33
1.68
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
37
245
1.54
1.66
1.4
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
49
2.26
1.64
1.5
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
14
3.59
1.61
1.0
1.0
mg/g
6.0
5.5
—
5
14
(40758558) Short blood count panel - Blood
188
1608
1.22
1.60
6.8
6.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
156
1308
1.24
1.60
1.9
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
79
607
1.34
1.60
1.8
2.1
nmol/l
379.3
372.6
0.13
67
569
(40768793) Breast Pathology biopsy report
8
173
0.46
1.59
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
92
724
1.31
1.58
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
293
2618
1.19
1.57
2.2
2.3
nmol/l
73.4
75.5
0.76
274
2378
(3024928) Oxygen saturation in Venous blood
20
114
1.77
1.57
6.9
4.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
29
443
0.64
1.57
1.7
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
53
383
1.41
1.56
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
107
1.80
1.56
1.7
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
171
1455
1.23
1.53
2.3
2.6
umol/l
7440.7
6029.1
0.13
146
1279
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
240
2114
1.20
1.50
3.8
3.4
e6/l
92.6
117.0
0.20
160
1454
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
79
1.92
1.50
1.4
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
101
1.80
1.50
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
36
245
1.49
1.45
1.6
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
53
389
1.39
1.44
1.6
1.7
g/l
1.2
1.3
0.26
47
358
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
201
1749
1.20
1.43
3.2
2.9
e6/l
18.9
101.4
1.48
144
1337
(40768797) Stomach Pathology biopsy report
101
816
1.27
1.43
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
62
468
1.35
1.42
4.1
4.4
%
0.0
0.6
—
6
111
(3022217) INR in Platelet poor plasma by Coagulation assay
78
610
1.31
1.41
26.5
18.0
inr
1.1
1.2
0.50
16
90
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
41
2.21
1.37
1.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
174
1500
1.21
1.37
3.1
3.3
mg/l
461.7
282.1
0.17
100
951
(3003327) Ova and parasites identified in Stool by Light microscopy
34
232
1.49
1.36
1.9
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
28
183
1.55
1.36
1.1
1.3
—
634.0
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
97
1.77
1.36
1.2
1.2
—
—
—
0
0
(3013512) EKG study
180
1558
1.20
1.35
3.6
3.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
105
1.73
1.34
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
1.5
—
1.3
—
0
18
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
42
2.16
1.34
1.0
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
90
1.79
1.34
1.9
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
40
0.00
1.33
0.0
1.8
—
1.4
—
0
31
(3041096) Erythrocytes [Presence] in Urine by Automated
206
1810
1.19
1.31
2.8
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
58
442
1.34
1.27
9.5
9.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
407
1.35
1.27
2.1
2.2
u/l
6747.4
3822.5
0.25
21
167
(44790049)
14
77
1.83
1.26
1.1
1.5
—
—
—
0
0
(44790048)
14
77
1.83
1.26
1.1
1.5
—
—
—
0
0
(44806118)
14
77
1.83
1.26
1.1
1.5
—
—
—
0
0
(44790047)
14
77
1.83
1.26
1.1
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
138
1173
1.21
1.25
2.4
2.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
25
2.41
1.24
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
70
1.87
1.24
1.2
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
127
1073
1.22
1.23
2.4
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
133
1.60
1.18
2.2
2.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
11
57
1.94
1.17
1.3
1.6
%
61.7
57.5
—
6
41
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
27
182
1.50
1.17
4.2
2.8
u/ml
3260.0
875.4
0.33
27
157
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
650
6290
1.21
1.16
4.8
4.4
mmol/l
2.9
2.8
0.26
599
5858
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
87
1.74
1.15
3.7
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
72
1.82
1.15
1.0
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
126
1.60
1.15
1.2
1.5
u/ml
108.5
110.8
—
8
28
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.1
—
82.4
—
0
26
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.1
—
27.5
—
0
26
(3009508) Creatinine [Moles/volume] in Urine
198
1755
1.17
1.13
3.8
3.1
mmol/l
7.5
7.6
0.19
170
1497
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
30
2.35
1.12
1.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
40
2.01
1.12
1.5
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
277
1.39
1.12
5.2
4.6
mmol/l
24.5
24.0
0.31
32
257
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
160
1.52
1.10
1.5
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
104
1.65
1.10
1.3
1.2
u/ml
1.8
6.0
—
8
48
(3023323) Follitropin [Units/volume] in Serum or Plasma
52
400
1.32
1.10
1.2
1.5
iu/l
53.3
25.0
1.63
37
343
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
53
409
1.32
1.09
2.5
2.2
ug/l
5.5
7.3
0.62
43
369
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
8
41
1.96
1.09
1.0
1.3
—
28.3
—
0
6
(3020961) Endomysium IgA Ab [Titer] in Serum
51
392
1.32
1.08
1.1
1.1
—
148.4
—
0
9
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
56
437
1.30
1.07
2.0
3.6
mmol/l
1.2
1.2
0.21
50
378
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
640
6198
1.19
1.06
4.3
4.0
mmol/l
4.8
4.7
0.16
589
5808
(3045414) Leukocytes [Presence] in Urine
36
263
1.39
1.05
2.0
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
162
1.50
1.05
1.4
1.4
ug/g
291.0
315.7
0.17
12
92
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
90
1.68
1.04
1.0
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
75
1.75
1.03
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
80
657
1.24
1.03
1.6
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
54
423
1.30
1.02
1.2
1.3
au/ml
101.4
29.0
—
5
24
(3000330) Specific gravity of Urine by Test strip
37
274
1.37
1.01
2.4
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
164
1447
1.17
1.00
1.4
1.4
g/l
2.1
2.2
0.56
97
893
(40760892) CBC W Ordered Manual Differential panel - Blood
174
1544
1.16
0.98
4.7
4.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
122
1052
1.19
0.97
5.0
4.2
ug/l
2.6
2.3
0.14
108
952
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.0
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
30
216
1.40
0.97
1.4
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
178
1585
1.16
0.96
3.9
4.0
mg/mmol
7.1
9.3
0.32
105
994
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
39
295
1.34
0.94
1.5
1.3
miu/ml
249.0
250.8
0.01
23
150
(3021788) Differential panel - Synovial fluid
15
93
1.63
0.94
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
52
1.74
0.92
2.3
3.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
55
1.83
0.92
1.1
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
98
833
1.20
0.92
4.7
3.9
%
23.2
21.3
0.45
41
357
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
126
1.52
0.92
3.2
3.9
%
53.8
56.7
0.32
19
126
(3004789) Transferrin [Mass/volume] in Serum or Plasma
93
787
1.21
0.92
1.8
2.3
g/l
2.4
2.4
0.16
84
728
(3017704) Immunofixation for Urine
6
28
2.15
0.91
1.2
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
35
263
1.35
0.89
9.6
2.4
—
—
—
0
0
(4268621)
12
71
1.70
0.89
2.3
2.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
42
1.91
0.88
1.0
1.4
—
290.0
—
0
5
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
136
1.48
0.87
1.3
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
13
80
1.64
0.85
1.5
1.3
mu/l
114.1
46.6
0.67
13
73
(4146454)
8
45
1.79
0.84
1.5
2.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
75
628
1.22
0.83
3.3
2.7
ug/l
0.7
0.8
0.42
52
366
(3011648) Oxygen content in Venous blood
8
46
1.75
0.82
2.8
6.7
%
9.4
12.0
—
8
46
(3026782) Osmolality of Urine
130
1145
1.16
0.82
2.3
2.5
mosm/kgh2o
529.9
552.8
0.52
108
982
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
105
1.53
0.82
1.3
1.2
u/ml
1.3
4.3
—
6
38
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
47
1.71
0.81
1.4
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
277
1.31
0.80
2.2
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
148
0.60
0.79
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
24
173
1.40
0.79
8.7
2.2
—
—
—
0
0
(1002224) Polysomnography panel
40
313
1.29
0.79
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
24
0.00
0.79
0.0
1.3
—
8.4
—
0
24
(3029937) Albumin [Presence] in Urine by Test strip
184
1667
1.14
0.79
3.7
3.7
estimate
0.0
0.0
1.08
64
606
(3024263) Appearance of Synovial fluid
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
27
200
1.36
0.77
1.3
1.6
iu/ml
0.0
0.1
—
6
31
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
149
1.42
0.76
1.1
1.1
u/ml
6.7
7.9
—
10
85
(3043410) Blood group antigens tested for on Red Blood Cells
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
24
2.09
0.74
1.6
1.3
—
6.7
—
0
7
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
167
1.39
0.74
1.2
1.1
u/ml
1.3
2.6
—
6
69
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
108
1.49
0.74
1.3
1.1
—
—
—
0
0
(4035726)
39
489
0.79
0.74
1.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
15
100
1.51
0.73
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
39
1.80
0.72
1.0
1.4
—
18.9
—
0
9
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
151
1.40
0.72
1.1
1.6
—
—
—
0
0
(4010399)
52
430
1.22
0.68
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
267
1.29
0.68
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
134
1202
1.14
0.67
2.3
2.4
e6/l
5.7
7.3
0.80
122
1057
(3044640) Blood type and Crossmatch panel - Blood
206
1899
1.12
0.66
2.2
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
145
1.39
0.66
1.1
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
609
5939
1.12
0.63
3.7
3.6
mmol/l
1.3
1.3
0.15
563
5526
(3027945) Reticulocytes/100 erythrocytes in Blood
64
545
1.19
0.63
3.1
3.0
%
1.7
1.8
0.04
53
499
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
199
1.32
0.63
1.8
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
110
979
1.14
0.63
1.7
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
50
1.61
0.61
2.8
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
88
1.49
0.61
1.3
1.4
nmol/l
0.5
0.5
0.22
13
81
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
20
0.00
0.60
0.0
2.2
—
74.5
—
0
20
(4034850)
25
192
1.31
0.60
7.3
9.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
52
1.54
0.59
1.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
22
0.00
0.59
0.0
1.2
—
337.6
—
0
15
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
114
1.41
0.59
1.1
1.0
u/ml
2.2
2.0
—
10
55
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
609
5947
1.11
0.59
12.7
10.7
ml/min/173m2
89.0
87.1
1.31
514
4809
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
23
0.00
0.58
0.0
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
89
1.47
0.58
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
149
1.35
0.58
1.2
1.1
u/ml
6.0
3.6
—
6
34
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
156
1429
1.11
0.57
2.2
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
148
1354
1.12
0.56
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
61
706
0.85
0.56
4.7
4.0
%
30.7
31.8
0.45
39
475
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
631
6182
1.11
0.54
4.3
4.0
mmol/l
1.5
1.5
0.33
588
5768
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
17
125
1.37
0.54
1.3
1.4
u/l
19.5
20.7
0.07
17
109
(3000475) Leukocytes [#/volume] in Synovial fluid
17
125
1.37
0.54
1.5
1.6
e6/l
6924.8
16080.1
0.85
12
89
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
108
1.40
0.53
1.1
1.1
u/ml
8.5
6.8
—
5
42
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
143
1.34
0.53
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
71
807
0.87
0.52
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
83
1.45
0.52
1.1
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
40
1.50
0.51
1.3
1.2
—
—
—
0
0
(4062490)
9
64
1.41
0.51
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
33
270
1.23
0.50
1.4
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
41
1.47
0.50
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
216
1.26
0.50
1.8
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
528
0.84
0.49
1.5
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
45
1.56
0.49
1.3
2.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
45
1.56
0.49
1.3
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
45
1.56
0.49
2.7
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
45
382
1.19
0.49
2.7
2.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
18
137
1.32
0.47
1.2
1.4
u/ml
222.5
230.3
—
10
83
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
274
0.80
0.44
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
202
1.25
0.44
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
202
1.25
0.44
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
113
1.33
0.43
6.1
3.3
mmol/l
3.1
2.8
—
9
70
(3004809) Band form neutrophils/100 leukocytes in Blood
6
91
0.66
0.42
5.0
3.4
%
0.5
1.0
—
6
74
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
91
0.66
0.42
7.5
4.1
u/ml
31.7
441.5
—
6
86
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
87
1.39
0.42
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
2.9
u/ml
723.4
733.1
—
5
32
(4281824)
8
57
1.41
0.42
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
58
1.38
0.41
3.5
3.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
79
1.40
0.41
1.4
1.4
nmol/l
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
17
0.00
0.40
0.0
1.1
—
36.8
—
0
12
(1761482) Bacteria [#/volume] in Urine by Culture
18
141
1.28
0.40
2.4
4.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
20
159
1.26
0.40
3.8
4.1
mmol/l
3.8
3.9
0.09
20
146
(3050129) First trimester maternal screen panel - Serum or Plasma
30
357
0.83
0.40
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
232
1.21
0.40
1.3
1.6
u/l
30.4
10.0
0.65
21
198
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
106
0.66
0.39
1.0
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
142
1.27
0.39
1.1
1.1
u/ml
0.1
1.7
—
5
65
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
261
1.20
0.38
2.6
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
68
1.33
0.37
2.7
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
13
98
1.33
0.37
1.6
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
55
488
1.14
0.37
4.1
4.1
ug/l
10.9
16.9
0.21
42
396
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.5
ug/l
5.0
6.9
—
5
32
(42529406) Shigella sp [Presence] in Stool by Culture
25
207
1.21
0.37
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
90
1.34
0.36
1.5
1.4
—
—
—
0
0
(4306422)
13
99
1.32
0.35
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
17
135
1.27
0.35
3.2
2.2
g/l
0.0
0.0
0.00
17
127
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
68
749
0.90
0.34
1.3
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
275
0.83
0.34
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
275
0.83
0.34
1.7
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
13
100
1.31
0.33
1.0
1.1
%
123.9
116.8
0.49
13
91
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
109
1.29
0.33
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
199
0.80
0.33
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
274
0.83
0.33
1.7
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
17
137
1.25
0.32
3.2
2.2
g/l
0.0
0.0
0.00
17
128
(4094501)
17
137
1.25
0.32
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
137
1.25
0.32
1.2
2.3
nmol/l
0.7
0.8
0.18
11
118
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
316
0.85
0.32
1.7
1.8
mg/l
2.6
3.0
0.11
16
226
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
147
1.23
0.31
3.1
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
102
1.28
0.30
1.7
3.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
26
222
1.18
0.29
1.8
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
22
185
1.19
0.29
3.8
4.2
mmol/l
1.3
1.3
0.07
22
180
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
225
0.84
0.26
1.8
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
13
104
1.25
0.26
1.9
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
104
1.25
0.26
4.0
2.5
%
17.3
16.6
—
6
60
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
19
160
1.19
0.25
3.0
2.3
g/l
0.9
1.0
0.07
19
144
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
77
1.17
0.24
1.2
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
84
0.71
0.24
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
37
332
1.12
0.23
3.0
2.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
147
0.81
0.23
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
147
0.81
0.23
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
232
0.86
0.23
1.6
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
39
1.28
0.23
1.6
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
295
1.12
0.22
7.2
1.8
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.2
nmol/l
35.8
33.0
—
5
32
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
79
1.27
0.22
1.2
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
17
144
1.18
0.22
3.2
2.2
g/l
0.0
0.0
0.01
17
135
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.3
—
43.6
—
0
10
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
8.2
—
0
10
(3004959) Base excess in Arterial cord blood by calculation
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
2.1
—
5678.7
—
0
10
(3006598) pH of Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.7
—
0.6
—
0
10
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
13.8
—
0.3
—
0
10
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(4015189)
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
219
0.86
0.20
1.7
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
77
723
1.07
0.20
1.9
2.4
%
19.1
23.0
2.01
66
623
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
183
1.15
0.20
2.9
2.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
14
0.00
0.20
0.0
2.6
—
0.1
—
0
8
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
111
0.81
0.20
1.9
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
49
1.23
0.20
1.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
115
0.78
0.20
1.9
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
99
1.22
0.19
1.8
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
41
376
1.10
0.19
4.3
3.9
ph
7.4
7.4
—
5
48
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
59
1.19
0.18
1.4
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
148
1.15
0.17
1.1
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
152
0.85
0.17
1.5
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
17
148
1.15
0.17
3.2
2.1
g/l
37.3
38.7
0.58
17
133
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
70
0.71
0.16
1.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
101
1.19
0.16
3.2
2.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
60
564
1.07
0.16
3.0
3.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
30
273
1.10
0.16
4.9
4.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
297
0.91
0.15
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
119
0.84
0.15
9.0
3.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
88
0.79
0.14
1.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
334
1.08
0.14
1.6
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
122
1.15
0.14
2.4
1.7
—
—
—
0
0
(3019225) pH of Specimen
49
519
0.94
0.13
4.3
4.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
220
0.91
0.12
1.6
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
143
1.12
0.11
1.8
1.6
nmol/l
0.4
0.3
—
9
116
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
172
1.11
0.11
3.0
2.2
g/l
10.7
10.7
0.02
19
151
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
136
0.88
0.11
3.4
3.5
—
2.1
—
0
16
(3015183) Erythrocyte sedimentation rate
5
46
1.09
0.09
1.6
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
30
282
1.07
0.09
1.8
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
37
390
0.95
0.09
5.6
3.0
e9/l
66.3
72.7
0.67
25
293
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.2
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
1.2
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
361
1.06
0.08
4.3
3.9
mmol/l
1.2
1.6
0.25
31
268
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
58
1.03
0.08
1.0
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.1
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
215
0.93
0.07
5.2
3.4
g/l
0.4
0.3
—
10
98
(3035637) Corticotropin [Mass/volume] in Plasma
8
75
1.07
0.07
1.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
37
353
1.05
0.07
6.6
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.0
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
195
1921
1.02
0.07
1.5
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
82
0.85
0.07
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
82
0.85
0.07
1.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
83
0.84
0.07
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
83
0.84
0.07
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
84
0.83
0.07
1.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
84
0.83
0.07
1.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
118
1.10
0.07
1.4
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
45
433
1.04
0.06
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
203
0.93
0.06
1.3
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
119
1.09
0.06
1.5
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
20
188
1.07
0.05
1.7
1.4
pmol/l
99.4
166.5
0.40
20
183
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
20
190
1.05
0.04
1.3
1.2
u/ml
4.0
10.8
—
6
34
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
92
1.09
0.03
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
86
871
0.99
0.02
1.6
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
254
2532
1.00
0.01
2.0
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
116
0.95
0.00
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
116
0.95
0.00
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
38
374
1.02
0.00
5.5
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
104
0.96
0.00
1.7
4.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
146
1.03
0.00
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
264
0.98
0.00
1.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
163
0.98
0.00
2.2
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
158
1.01
0.00
1.5
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
557
1.01
0.00
3.3
3.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
38
378
1.01
0.00
6.5
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
131
0.99
0.00
1.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
381
1.00
0.00
6.7
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
38
379
1.00
0.00
6.5
1.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
83
0.96
0.00
2.1
1.5
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
82.2
—
0
5
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
169.4
—
0
5
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
237.4
—
0
5
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
15.2
—
0
5
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(21494434) Karyotype in Bone marrow
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
3.3
—
0
9
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
120
1.00
0.00
1.9
2.4
ug/min
16.6
139.4
—
7
73
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
72
0.97
0.00
1.1
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
27
270
1.00
0.00
1.5
1.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
100
1.00
0.00
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
130
1.00
0.00
1.8
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
59
1.02
0.00
1.0
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
440
1.00
0.00
2.9
2.8
e9/l
4.4
4.1
0.46
39
363
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.0
—
19.1
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
61
0.98
0.00
1.2
1.2
nmol/l
2.0
1.4
—
6
54
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
51
0.98
0.00
1.2
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
59
1.02
0.00
1.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
62
0.97
0.00
3.3
3.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.9
—
0
6
(3005570) Glucose [Moles/volume] in Urine
6
63
0.95
0.00
5.3
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
87
0.92
0.00
1.1
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_ANOMAPUPFUNC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ANOMAPUPFUNC | 1.182 [0.96, 1.46] | 0.124 |
| Birth year | 0.993 [0.98, 1.0] | 0.099 |
During the follow-up period (1.1.1998 — 31.12.2019), 169 out of 2968 females with H7_ANOMAPUPFUNC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_ANOMAPUPFUNC | 1.53 [1.15, 2.03] | 0.003 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 134 out of 1746 males with H7_ANOMAPUPFUNC died.
Mortality risk
Mortality risk for people of age
years, who have H7_ANOMAPUPFUNC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.131% | 0.289% |
| 5 | 0.718% | 1.814% |
| 10 | 1.711% | 4.479% |
| 15 | 3.221% | 8.656% |
| 20 | 5.523% | 14.409% |
Relationships between endpoints
↥Index endpoint: H7_ANOMAPUPFUNC – Anomalies of pupillary function
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data